Clobetasol Propionate Ointment USP — Class I drug recall D-0375-2022
Terminated recall by Taro Pharmaceuticals U.S.A., Inc., reported 2022-01-19, distributed nationwide. Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
| Recall number | D-0375-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY, United States |
| Recall initiated | 2021-12-15 |
| Classified | 2022-01-18 |
| Reported by FDA | 2022-01-19 |
| Terminated | 2023-12-04 |
| Distributed | Nationwide (US) |
| Quantity | 96 tubes |
| Reason classes | microbial contamination, sterility |
| NDC | 51672-1258, 51672-1258-01, 51672-1258-02, 51672-1258-03, 51672-1258-06, 51672-1259, 51672-1259-01, 51672-1259-02, 51672-1259-03, 51672-1259-06, 51672-1294, 51672-1294-01, 51672-1294-02, 51672-1294-03 |
| Lot numbers | AC13786 |
| Expiration dates | 2022-12-20 |
Product
Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3
Reason for recall
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0375-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.